Gridai Technologies Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$2.91

-0.22 (-7.03%)

As of Feb 8, 2:29 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,384.5% upside

Low Target $28.55

Average Target $43.20

High Target $44.32

Current Price $2.91

Current
$2.91

Target
$43.20

$28.55 $43.20 avg $44.32

Scenario Analysis

Bear Case

$28.55

881.1%

Low target

Base Case

$43.20

+1,384.5%

Avg target

Bull Case

$44.32

+1,423.0%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$46.78

-93.8% from high

52-Week Low

$26.60

+-89.1% from low

Target vs 52W High

$43.20

-7.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%